EMD Serono lays out MS therapies’ immune-system suppression risks in new campaignnews2024-01-17T20:05:19+00:00January 17th, 2024|Endpoints News|
Pfizer and BioNTech urge US patent review board to take on Moderna’s Covid patentsnews2024-01-17T19:32:54+00:00January 17th, 2024|Endpoints News|
Roche’s TIGIT win limited by standard of care change, lack of global studynews2024-01-17T19:24:24+00:00January 17th, 2024|Endpoints News|
European Commission launches new alliance to address critical drug shortagesnews2024-01-17T18:37:49+00:00January 17th, 2024|Endpoints News|
JPM recap: Where the money is in biotech, alternative upturn indicators and morenews2024-01-17T18:29:35+00:00January 17th, 2024|Endpoints News|
Gilead cancels biologics expansion in Oceanside, to move operations to Bay Areanews2024-01-17T17:43:01+00:00January 17th, 2024|Endpoints News|
Humira biosimilar market remains stagnant, with AbbVie losing only 2% of market share, Samsung report showsnews2024-01-17T17:35:45+00:00January 17th, 2024|Endpoints News|
FDA+ roundup: Sen. Tillis goes after Biden administration for supporting march-in rightsnews2024-01-17T17:31:04+00:00January 17th, 2024|Endpoints News|
Lee’s Pharma to develop Windtree drug in China; Acurx shares PhIIb antibiotic data; Granata raises $14Mnews2024-01-17T16:21:18+00:00January 17th, 2024|Endpoints News|
Venture capital firm General Catalyst is buying an Ohio-based health systemnews2024-01-17T15:19:01+00:00January 17th, 2024|Endpoints News|
